Universal Beteiligungs und Servicegesellschaft mbH Reduces Stock Position in Acadia Healthcare Company, Inc. $ACHC

Universal Beteiligungs und Servicegesellschaft mbH lessened its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 64.9% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 31,821 shares of the company’s stock after selling 58,941 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Acadia Healthcare were worth $788,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in ACHC. Allworth Financial LP increased its stake in shares of Acadia Healthcare by 676.4% in the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock worth $31,000 after purchasing an additional 1,177 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after purchasing an additional 497 shares during the period. CWM LLC increased its position in Acadia Healthcare by 105.1% in the second quarter. CWM LLC now owns 2,633 shares of the company’s stock worth $60,000 after buying an additional 1,349 shares in the last quarter. Quent Capital LLC bought a new position in shares of Acadia Healthcare in the third quarter worth about $71,000. Finally, Steward Partners Investment Advisory LLC lifted its position in shares of Acadia Healthcare by 639.5% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 3,372 shares of the company’s stock valued at $77,000 after buying an additional 2,916 shares in the last quarter.

Wall Street Analysts Forecast Growth

ACHC has been the topic of several research analyst reports. TD Cowen restated a “reduce” rating on shares of Acadia Healthcare in a research report on Friday, January 16th. UBS Group reduced their price target on shares of Acadia Healthcare from $28.00 to $24.00 and set a “buy” rating on the stock in a report on Wednesday, December 3rd. Leerink Partners downgraded shares of Acadia Healthcare from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 3rd. Deutsche Bank Aktiengesellschaft decreased their target price on Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating on the stock in a research report on Wednesday, December 3rd. Finally, Guggenheim lowered their target price on Acadia Healthcare from $29.00 to $27.00 and set a “buy” rating for the company in a research report on Monday, November 10th. Six analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $18.62.

Acadia Healthcare Trading Up 3.0%

NASDAQ:ACHC opened at $13.44 on Monday. The firm has a 50-day simple moving average of $14.35 and a 200-day simple moving average of $19.23. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $45.47. The firm has a market cap of $1.24 billion, a P/E ratio of 11.49, a P/E/G ratio of 3.82 and a beta of 0.88. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.44 and a current ratio of 1.44.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, November 5th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.01. The company had revenue of $851.57 million during the quarter, compared to the consensus estimate of $852.43 million. Acadia Healthcare had a net margin of 3.29% and a return on equity of 7.66%. Acadia Healthcare’s revenue was up 4.4% compared to the same quarter last year. During the same period last year, the firm earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.350-2.450 EPS. Equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.